Skip to content

Development and Preliminary Application of a Multidimensional Frailty Intervention Programme for Elderly Heart Failure Patients

Development and Preliminary Application of a Multidimensional Frailty Intervention Programme for Elderly Heart Failure Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500113504
Enrollment
Unknown
Registered
2025-11-29
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frailty

Interventions

Intervention group:The intervention group underwent a 12-week multidimensional intervention program in addition to the health education provided to the control group. The physical dimension primarily
the psychological dimension centered on cognitive training
and the social dimension mainly involved nurse-led group support and family peer communication.
Control group:Health Education and Post-Discharge Follow-Up: During hospitalization, educate patients on heart failure (HF) and frailty-related knowledge, the benefits and importance of exercise, and

Sponsors

Nursing College of Xinxiang Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 100 Years

Inclusion criteria

Inclusion criteria: (1) Age >= 60 years; (2) Patients with stable heart failure (HF) meeting the diagnostic criteria of the Chinese Guidelines for Diagnosis and Treatment of Heart Failure 2024 and classified as New York Heart Association (NYHA) functional class I-III; (3) Frailty criteria: Frailty Frailty Frailty Frailty (FFP) score > 2 points; (4) Alert and able to communicate effectively. (5) Voluntarily sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Patients with significant concomitant physical illnesses; (2) Patients with significant functional limitations due to conditions such as lumbar disc herniation, fractures, or hemiplegia; (3) Patients taking medications that may cause a state of apparent debility (e.g., antidepressants, levodopa, donepezil hydrochloride); (4) Patients participating in other clinical interventional studies.

Design outcomes

Primary

MeasureTime frame
Tilburg Frailty Indicator;

Secondary

MeasureTime frame
Comprehensive Geriatric Assessment;Readmission;

Countries

China

Contacts

Public ContactXiaoLei Gao

Xinxiang Medical University

gaoxiaolei0926@163.com+86 135 2385 0686

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026